International Biotechnology Trust’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $381K | Hold |
17,000
| – | – | 0.13% | 62 |
|
|
2023
Q2 | $692K | Sell |
17,000
-76,000
| -82% | -$3.09M | 0.21% | 53 |
|
|
2023
Q1 | $4.5M | Sell |
93,000
-51,000
| -35% | -$2.47M | 1.26% | 29 |
|
|
2022
Q4 | $5.49M | Buy |
144,000
+123,000
| +586% | +$4.69M | 1.7% | 20 |
|
|
2022
Q3 | $1.06M | Buy |
21,000
+20,158
| +2,394% | +$1.01M | 0.34% | 51 |
|
|
2022
Q2 | $21K | Sell |
842
-410,158
| -100% | -$10.2M | 0.22% | 64 |
|
|
2022
Q1 | $617K | Sell |
411,000
-38,000
| -8% | -$57K | 0.14% | 63 |
|
|
2021
Q4 | $17.9M | Hold |
449,000
| – | – | 3.98% | 8 |
|
|
2021
Q3 | $16.7M | Hold |
449,000
| – | – | 4.03% | 9 |
|
|
2021
Q2 | $18.9M | Buy |
449,000
+41,000
| +10% | +$1.73M | 5% | 7 |
|
|
2021
Q1 | $19.3M | Buy |
408,000
+75,000
| +23% | +$3.55M | 5.11% | 6 |
|
|
2020
Q4 | $20.3M | Buy |
333,000
+34,000
| +11% | +$2.08M | 5.55% | 5 |
|
|
2020
Q3 | $14M | Hold |
299,000
| – | – | 4.5% | 7 |
|
|
2020
Q2 | $15.1M | Buy |
299,000
+30,000
| +11% | +$1.52M | 5.03% | 6 |
|
|
2020
Q1 | $12M | Buy |
269,000
+155,000
| +136% | +$6.9M | 5.46% | 7 |
|
|
2019
Q4 | $5.47M | Sell |
114,000
-122,000
| -52% | -$5.85M | 1.97% | 17 |
|
|
2019
Q3 | $7.98M | Sell |
236,000
-23,000
| -9% | -$778K | 3.69% | 9 |
|
|
2019
Q2 | $11.6M | Buy |
259,000
+18,507
| +8% | +$832K | 4.32% | 7 |
|
|
2019
Q1 | $9.05M | Buy |
+240,493
| New | +$9.05M | 3.34% | 8 |
|